Clinical trials recruiting for Osteosarcoma

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• AOH1996 for the Treatment of Refractory Solid Tumors
  NCT05227326 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Agnostic Therapy in Rare Solid Tumors
  NCT06638931 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 8 locations
• Atezolizumab in Combination With Stereotactic Body Radiation Therapy (SBRT) and Surgery for Relapsed Osteosarcoma
  NCT06492954 · Phase: Phase 1 · Ages: Up to 50 Years · Sex: All (male and female) · 1 location
• B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
  NCT04897321 · Phase: Phase 1 · Ages: Up to 21 Years · Sex: All (male and female) · 1 location
• Clinical Orthopaedic Data Bank (Acute and Chronic)
  NCT00411060 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Early Ageing During Therapy in AYA Cancer Patients
  NCT05062707 · Phase: Not specified · Ages: 18 Years to 39 Years · Sex: All (male and female) · 1 location
• Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
  NCT01790152 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 79 locations
• Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
  NCT07628634 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• PET-imaging of Two Vartumabs in Patients With Solid Tumors
  NCT06645808 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Pulmonary Resectable Osteosarcoma Treated by Metastasectomy and Pre-operative Immunotherapy and Stereotactic Body Radiotherapy (PROMIS): a Prospective Clinical Trial
  NCT06114225 · Phase: Phase 2 · Ages: 10 Years to 65 Years · Sex: All (male and female) · 1 location
• START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer
  NCT05492682 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• Safety and Feasibility of Intraoperative Visualization With Cytalux in Children
  NCT06235125 · Phase: Phase 1 · Ages: 6 Years to 17 Years · Sex: All (male and female) · 1 location
• Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
  NCT04282044 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 6 locations
• Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
  NCT05235165 · Phase: Phase 3 · Ages: Up to 50 Years · Sex: All (male and female) · 233 locations
• Use of GnRHa During Chemotherapy for Fertility Protection
  NCT05328258 · Phase: Phase 3 · Ages: 14 Years to 42 Years · Sex: Female · 17 locations

Related conditions

Trials recruiting for Osteosarcoma often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Osteosarcoma trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.